Peer-reviewed veterinary case report
Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study.
- Journal:
- Veterinary therapeutics : research in applied veterinary medicine
- Year:
- 2004
- Authors:
- Thompson, Lori A et al.
- Affiliation:
- Animal Allergy and Skin Disease Center · United States
- Species:
- dog
Abstract
The oral use of human recombinant interferonalpha-2b at 1,000 IU/ml/day appeared to provide only a transient benefit as compared with placebo for management of idiopathic recurrent superficial pyoderma in dogs. Further investigation using a larger population of dogs is needed to determine whether interferon is effective for long-term treatment of this condition.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/15150732/